integrins degrades members of the Rho family of GTP ases, such as Rac and RhoA, which are themselves activated by β3-integrins to mediate focal cell adhesion (Bialkowska et al., 2000) , and (ii) epidermal growth factor receptor signaling via the ERK/MAPK pathway activates mCp, which induces the proteolytic abrogation of cell adhesion (Glading et al., 2000) .
Besides calpains other protease systems, such as matrix metalloproteinases (MMPs) and the urokinase/urokinase receptor (uPAR)/plasmin system, are intimately connected to the integrins and ECM during the process of cell migration. Regulation of MMP expression due to cell-ECM contacts has been reported, and in particular diverse integrins were shown to mediate the expression of the primary matrix degrading proteinases, MMP-9 and MMP-2 (Huhtala et al., 1995) . Tumor cell migration through the ECM requires the cooperation of cell adhesion and local proteolysis of ECM components such as basement membranes, collagens, fibronectin and laminin. MMPs are responsible for ECM breakdown under both normal and pathological conditions (reviewed in Itoh and Nagase, 2002) . Secretion of MMPs, predominantly of MMP-2 and MMP-9, has been demonstrated in various cellular systems to correlate with the capacity of tumor cells for invasion and metastasis (Stetler-Stevenson et al., 1993) .
Although MMPs and the uPA system seem to play the major role in tumor development and invasion, recent results from various studies also point to the relevance of calpain within these processes. For instance, increased calpain activity has been detected in breast cancer tissues (Shiba et al., 1996) , and in human renal cell carcinomas significantly higher levels of µCp expression were found in tumors metastazing to peripheral lymph nodes compared to tumors that have not metastasized (Braun et al., 1999) . Interestingly, calpain-mediated proteolysis of the tumor suppressor protein, neurofibromatosis type 2, is associated with the development of schwannomas and meningiomas (Kimura et al., 2000) . Finally, elevated calpain activity in chronic lymphocytic leukemic cells (Witkowski et al., 2002) and involvement of calpains in differentiation of leukemic cells have been reported as well (Deshpande et al., 1995) . However, it is not clear how the calpain/calpastatin system is regulated in leukemic cells at diverse stages of differentiation.
In view of the fact that calpain is required for MMP-2 and uPA-expression in SV40 large T-antigen-immortalized cells (Postovit et al., 2002) , and that the gelatinases MMP-2 and MMP-9 are highly expressed in leukemic cells (Ries et al., 1999) , we focused on a potential interaction between the calpain/calpastatin system and these two gelatinases during leukemic cell invasion. Furthermore, we addressed whether this interaction depends on the cellular differentiation stages, i.e. monocytic, macrophage-or granulocyte-like stages.
To address these issues we cultivated the human monocytic cell line THP-1 under serum-free conditions in RPMI 1640 medium supplemented with 1% Nutridoma (Roche, Basel). This cell line can be further stimulated to differentiate into a macrophage-or granulocyte-like stage, respectively (Auwerx, 1991; Drexler et al., 1995) . For induction of macrophage- (Hubermann and Callaham, 1979) or granulocyte-like (Collins et al., 1978) differentiation cells were treated for 24 or 48 hours with either PMA (80 nM) or DMSO (1.28 µM), respectively. Compared to starting conditions neither PMA nor DMSO were cytotoxic throughout a 48 hour study period to a significant extent as assessed by co-staining with annexin V fluorescein isothiocyanate (FITC) and propidium iodide (PI) (Figure 1 ). In further experiments, leukemic cells were stimulated to differentiate by pre-incubation with the indicated concentrations of PMA-or DMSO for 24 h. PMAstimulated macrophage differentiation of THP-1 was confirmed by induction of vimentin expression (Cabanas et al., 1990 ; Figure 2B ), as well as by microscopic (Fig-Fig. 1 Effect of PMA and DMSO on the Viability of Leukemic THP-1 Cells. Cell viability was assessed by flow cytometry, simultaneously monitoring FITC-labeled annexin V binding and propidium iodide (PI) uptake. THP-1 (DSMZ # ACC 16) cells (5×10 6 ) were treated with PMA or DMSO to induce macrophage-or granulocyte-like differentiation, respectively. Routine cell culture was performed in RPMI 1640 medium (PAA, Linz, Austria) supplemented with 10% fetal calf serum (PAA) and 1% glutamine solution (Gibco-BRL, Paisley, UK) at 37°C in a humidified 5% CO 2 incubator. Cell differentiation in serum-free medium supplemented with 1% Nutridoma-SP (Roche, Mannheim, Germany) was stimulated by addition of 80 nM PMA (Sigma, St. Louis, USA) or 1.28 µM DMSO (Fluka, Buchs, Switzerland) for 24 or 48 hours. All cell culture materials were purchased from NUNC, (Rochester, USA). After treatment with PMA or DMSO, cells were resuspended in 2 ml of annexin V binding buffer, and finally analyzed with FITC-annexin V and PI (9:1) for 5 min at room temperature according to the manufacture´s protocol (Roche). For preparation of cytosolic extract, cells were resuspended in freshly prepared lysis buffer (10 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, pH 7.5), supplemented with 1% protease inhibitor cocktail set III (Calbiochem, San Diego, USA), and lysed by four cycles of freezing and thawing. Total protein concentration was determined by the BCA method (Smith et al., 1985) . Cytosolic extracts were then mixed with sample buffer, heated for 2 -5 minutes at 95°C and electrophoretically resolved on SDS-Tris glycine polyacrylamide (10%) gels. Finally, samples were transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) and probed with a monoclonal anti-human vimentin antibody (Novocastra, Newcastle, UK). Antibody/protein complexes were detected with anti-mouse horse radish peroxidase (HRP)-linked IgG (New England Biolabs, Beverly,USA), using the SuperSignal ® chemiluminescence detection kit (Pierce, Rockford, USA). (C) Increase of the macrophage-specific CD69 [arrow, anti-CD69 phycoerythrin (PE); Caltag, Burlingame, USA] and (D), fading of hematopoietic progenitor marker CD34 (arrow, anti-CD34-FITC; Caltag) were observed using fluorescence-assisted analysis. For this, PMA-stimulated cells were washed and incubated for 30 minutes on ice with the appropriate antibody and subsequently analyzed using a flow cytometer (XL-MCL, Coulter). Blue, isotype control; red, untreated cells; green, treated cells. Results are representative of three replicas. ure 2A) and fluorescence-assisted cytometric analysis ( Figure 2C-D) . We detected an increase in the expression level of the macrophage-specific CD69 ( Figure 2C ), a differentiation marker of cells becoming adherent, with a simultaneous reduction of the hematopoietic progenitor marker CD34 ( Figure 2D ). In addition, cells incubated with DMSO were stained with Wright-Giemsa-reagent ( Figure 3A) , exhibiting granulocyte subcellular components concomitantly with the reduction of both the hematopoietic progenitor marker CD34 ( Figure 3B ) and of α-naphthyl acetate esterase activity (data not shown).
Summarizing the native (80 kDa) and the autolytical product (76 kDa) of the large subunit, calpain protein levels in the cytosolic extracts as determined by Western blotting were nearly unchanged after stimulation of the leukemic cell lines with PMA or DMSO ( Figure 4A ). Further, we did not detect significant differences in hydrolysis of the fluorogenic peptide substrate Suc-LY-amc in cytosolic extracts ( Figure 4B, bars 1) . This activity was reduced by CP1B ( Figure 4B, bars 2) , a highly specific calpain inhibitor (K i values: 0.2 nM for calpain, 6 µM for cathepsin L, ≥ 500 µM for cathepsin B and caspase 3) derived from the B motif of calpastatin (Gil-Parrado et al., 2003b) , indicating that a significant part of the Suc-LYamc hydrolytic activity resulted from calpain. In addition, cytosolic extracts of cells pre-incubated for 24 h with 954 O. Popp et al. Figure 1 ) for calpain expression in THP-1 cells indicate no significant differences in the expression of the calpain large subunit (80 kDa, 76 kDa). Cytosolic extracts were electrophoretically separated and transferred to a nitrocellulose membrane as described in Figure 2 . The samples were probed against a monoclonal anti-human calpain antibody (RDI, Flanders, USA), recognizing the native (80 kDa) and the autolytic product (76 kDa) of the calpain large subunit as well. (B) Calpain activity in cytosolic extracts (n= 3) from cells either pre-incubated or not with CP1B (50 µM, CP1B STI) for 24 h revealed no significant differences between unstimulated and differentiation-stimulated cells (bars 1) as measured by hydrolysis of the fluorogenic peptide substrate Suc-LY-amc. Most of the Suc-LY-amc hydrolysis could be inhibited by pre-incubation with the specific calpain inhibitor CP1B (10 nM, Sigma; bars 2), indicating that calpain is mainly responsible for this activity. Further, pre-incubation of cells with CP1B (50 µM) for 24 h markedly reduced the calpain activity since non significantly differences were detected between CP1B-pre-incubated cells before (bars 3) and after addition (bars 4) of CP1B (10 nM) during the activity assay. As positive control, purified human µCp (5 nM) isolated from erythrocytes was used. The activity assay contained 100 mM DTT, 20 mM CaCl 2 , 25 mM Suc-LY-amc and appropriate amounts of sample (5 µg cytosolic extracts). All experiments were performed in triplicate. (A) The cell invasion assay was performed as previously described (Zang et al., 2000) . THP-1 cells either untreated or stimulated to differentiate with PMA and DMSO, were pre-incubated or not with CP1B (50 µM) for 24 h (CP1B STI). The cells (1×10 5 ) were washed and then plated on a 6 µm pore transwell insert (Costar, Cambridge, USA) coated with 20 µg Matrigel (mouse ECM; Becton Dickinson, Franklin Lakes, USA). The upper and lower compartments of the transwell chamber contained RPMI medium supplemented with 1% Nutridoma in the presence or absence of CP1B (50 µM) (CP1B INV). The lower compartment contained 1% fetal calf serum to induce chemotactic cell migration. After 24 h of incubation at 37°C and 5% CO 2 , cells that had transmigrated either into the lower compartment or remained at the filter were quantified using a Neubauer chamber (cell number) or a fluorescence reader (F 635nm ; Tecan, Maennedorf, Switzerland), respectively. Remarkably, cells cultivated in Nutridoma or treated with DMSO were only found in the lower compartment, in contrast to cells treated with PMA that remained at the filter after transmigration. Briefly, transmigrated cells that remained at the filter were rinsed in phosphate-buffered saline (PBS) and immersed for 10 minutes in 3.7% freshly prepared formaldehyde. Thereafter, these cells were permeabilized for 2 minutes with 0.2% Triton X-100. Finally, cells were stained with 20 µg/ml PI (DNA-label) for 30 minutes before fluorescence readings. The relative migration (invasion index) was calculated by setting the number of migrated cells without CP1B addition in each treatment [Nutridoma (monocytic): 2354 ± 352 cells + 0 F 635nm ; PMA-treated cells (macrophage-like): 0 cells + 368 ± 50 F 635nm ; DMSOtreated cells (granulocyte-like): 7020 ± 1404 cells + 0 F 635nm ] as 100%. Note that pre-incubation of the cells with CP1B for 24 h significantly reduced the ECM invasiveness of THP-1 cells. Cell viability as assessed by the trypan blue-exclusion dye test (Sigma) amounted to 96 ± 5%. The values are given as mean of four independent experiments. (B) Analysis of the secreted proenzyme forms of MMP-2 and MMP-9 was performed by zymography using minigels containing 0.1% gelatin according to the manufacture´s protocol (Invitrogen, Carlsbad, USA). Aliquots of conditioned media (8 µg total protein) collected from the upper compartment of the invasion chamber were subjected to zymography. Remarkably, secretion of MMP-9 (and to a lesser degree of MMP-2) detected by gel scanning of the lysis area (Jaroslava et al., 1999) was significantly diminished in cells that had been pre-incubated with CP1B for 24 h. In contrast, addition of CP1B only during the invasion process did not reduce transmigration capacity (A) nor MMP release (B). As control for MMP-2 and MMP-9 release, conditioned medium from HT 1080 cells was used (M) (Stanton et al., 1998). cell-permeable CP1B were also analyzed for Suc-LY-amc hydrolysis. This treatment reduced significantly the Suc-LY-amc hydrolytic activity ( Figure 4B, bars 3) , again suggesting the inhibition of calpain activity throughout the incubation period. Finally, and consistent with these results, exogenous addition of CP1B to the latter extracts during the activity assay did only slightly further diminish Suc-LY-amc hydrolytic activity ( Figure 4B, bars 4) . Thus, these results conclusively confirm that pre-incubation with CP1B for 24 h reduces significantly calpastatin-inhibitable Suc-LY-amc hydrolysis, and therefore, calpain activity.
Since several calpain substrates are components of focal adhesion complexes whose remodeling is required for cellular migration, we studied the influence of calpain activity on the invasiveness of THP-1 cells using a Matrigel-based (ECM) transwell invasion assay in the presence or absence of CP1B. Before applying the cells in the invasion assay, basal and differentiation-stimulating cultivation of THP-1 cells was performed in the presence and absence of the calpain inhibitor as outlined above. The invasion index was defined as relative migration by setting the number of untreated cells that had migrated to the lower compartment as 100%. Remarkably, the invasion index of both differentiation-stimulated and untreated cells was significantly reduced after pre-incubation with CP1B for 24 h ( Figure 5A) .
To evaluate a possible interaction between the calpain/calpastatin system and MMPs, culture supernatants of THP-1 cells either pre-incubated or not with CP1B during (i) differentiation, (ii) invasion or (iii) differentiation and invasion were analyzed for secreted MMP-2 and MMP-9 using gelatin-incorporated SDS polyacrylamide gels. This zymographic analysis of THP-1 culture supernatants showed a constitutive secretion of MMP-2 and MMP-9 in their proenzyme form with apparent molecular masses of 72 and 94 kDa, respectively. An additional band at 180 kDa appears to represent the MMP-9 dimer as observed under non-reducing condition of zymography gels (Olson et al., 2000) (Figure 5B) . Stimulation of the cells with PMA or DMSO significantly augmented the release of MMP-9 but not of MMP-2, which is in accord with previous findings in these cells (Van Ranst et al., 1991) . Treatment of the cells for 24 hours with CP1B during cultivation under basal conditions as well as during stimulation with PMA or DMSO induced a prominent down-regulation of MMP-9 and to a lesser degree also of MMP-2 secretion ( Figure 5B ).
To rule out that MMP-2 and -9 secretion as well as reduced invasiveness were results of PMA-or DMSO-induced cell death, cell viability was monitored by cell staining with trypan blue after transmigration, exhibiting no relevant cell death (data not shown). On the other hand, there is ample evidence suggesting that CP1B is not cytotoxic, e.g. CP1B (50 µM) prevents ionomycin-induced apoptosis of LCLC 103H and COS 7 cells (Gil-Parrado et al., 2002) . Further indirect evidence for the noncytotoxicity of CP1B is provided by the observation that addition of CP1B during the transmigration assay (Figure 5, CP1B INV) for 24 hours did not affect invasion (Figure 5, bars 3) or MMP-expression ( Figure 5, lanes 3) .
Since addition of CP1B only during the invasion had no 956 O. Popp et al. THP-1 cells, either unstimulated (Nutridoma) or treated with PMA or DMSO, were cultivated for 24 h without or with CP1B (50 µM). Thereafter, total RNA was isolated using the RNeasy ® Kit (Qiagen, Hilden, Germany) according to the manufacturer´s protocol. The isolated RNA was reverse transcribed in cDNA with the First Strand cDNA Synthesis Kit (Roche). Primers for RT-PCR were purchased from Search LC (Heidelberg, Germany). Quantification of mRNA levels was carried out by automated real-time RT-PCR (LightCycler™, Roche). mRNA levels of MMP-2 and MMP-9 were normalized to that of the house-keeping gene GAPDH. The relative mRNA expression was calculated by setting the normalized mRNA levels of cells (unstimulated and stimulated with PMA or DMSO) without inhibitor treatment as 100%. Note that reduced mRNA expression of MMP-2 and especially of MMP-9 correlates with the diminished secretion of these proteinases during the ECM invasion by THP-1 cells (see Figure 5B ).
effect on the release of these two MMPs, we hypothesized that the calpain/calpastatin system might regulate primarily the expression of MMPs rather than their secretion. Therefore, we quantified the mRNA expression levels of MMP-2 and MMP-9 from unstimulated and differentiation-stimulated cells cultivated for 24 h in the presence or absence of CP1B (Figure 6 ). Indeed, a significant reduction of the gelatinase mRNA levels from cells pre-incubated with CP1B was found using real-time quantitative PCR. Noteworthy, the CP1B-mediated decrease was observed in unstimulated leukemic cells as well as in their macrophage-and granulocyte-like stages.
The stronger reduction of MMP-9 mRNA levels compared to those of MMP-2 correlated with both fewer proenzyme release of MMP-9 than of MMP-2 as shown by zymography ( Figure 5B ) and reduced invasiveness ( Figure 5A ). Since invasion requires extracellularly active proteases for breakdown of the ECM, one can expect that the amount of released proMMPs correlates with their activation during the invasion process (Nagase and Woessner, 1999) . Although calpains are localized mostly intracellularly, several reports indicated the presence of extracellular mCp on collagen fibrils (Badalamante et al., 1987) , in endoneural collagen fibrils and the basal laminae of Schwann cells (Mata et al., 1991) , around the cartilagenous matrix (Shimizu et al., 1991) , and in extracellular fibrous tissues, calluses and perivascular areas (Nakagawa et al., 1994) . To evaluate whether extracellular calpain might have been involved in the invasion process, we analyzed the culture supernatants of the upper compartment of the invasion chamber for the presence of secreted calpain. However, using an ELISA that had been optimized for calpain detection in conditioned medium, we could not detect any increase in the calpain release during transmigration by these leukemic cells independently on the differentiation stage (data not shown). Nevertheless, we would like to emphasize that our results do not exclude the possibility that activated calpain bound to the cell membrane (Gil-Parrado et al., 2003a) of migrating cells might have contributed to ECM degradation during invasion.
In summary, we have demonstrated that the specific calpain inhibitor, CP1B, reduces ECM invasion as well as mRNA expression of MMP-9 and MMP-2 and thus also the secretion of these proteinases by leukemic (THP-1) cells independently of their differentiation stages. This is the first report showing that the calpain/calpastatin system mediates MMP-mRNA expression of leukemic (THP-1) cells and as a consequence their invasiveness. Our evidences extend recent reports suggesting the involvement of calpain activity on the regulation of MMP-2 during SV40 large T-antigen-mediated immortalization of fibroblasts lacking the gene for the small subunit of calpain (Postovit et al., 2002) . How the calpain/calpastatin system regulates the invasiveness of non-transformed hematopoietic cells (e.g., monocytes) as well as of cells with different malignancies remains to be investigated. In addition, the precise mechanism(s) by which calpain influences the expression of these MMPs still deserves investigation. Interestingly, calpain has been reported to be involved in the ERK/MAPK signaling pathway (Glading et al., 2000) , which is also known to modulate MMP-9 mRNA expression (Westermarck and Kähäri, 1999) . Understanding the mechanism of MMP regulation by the calpain/calpastatin system may lead to the development of novel (antiproteolytic) therapeutic approaches against leukemic diseases.
